# Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment

> **NCT03207399** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 1 (actual)

## Conditions studied

- Hepatitis C, Chronic
- Lung Transplant

## Interventions

- **DRUG:** Epclusa

## Key facts

- **NCT ID:** NCT03207399
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-15
- **Primary completion:** 2019-03-25
- **Final completion:** 2019-03-25
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Enrollment terminated due to not having any other eligible participants.
- **Last updated:** 2019-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03207399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03207399, "Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03207399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*